|Does this sound good ?
Jul 23, 2002
I am currently taking Norvir, Crixivan, Videx, and Zerit. My cd4's are 778 and VL is <50. I have hyperlipidemia and lipodystrophy. Anyway my Doctor has suggested a one month STI in order to do a geno and a phenosense to see if we can find a better combo. We are anxiously awaiting the approval of Atazanavir because of the study results on lipid levels. So do you think a change at this time is good ?
Response from Dr. Little
In general, I think that the ideal way to change therapies is to start and stop without much of a drug interruption - in people who are fully suppressed on their previous regimen. That is, if your viral load is less than 50 on treatment, I think it is unlikely that a drug resistance test one month off treatment will offer you much more guidence than you would have gotten by just reviewing those medications that you have previously tried and either failed or developed toxicity. I don't think there is much harm in this approach, I simply think this is not the best way to time a resistance test. If you do find useful information, then you may clealy use this to select your next regimen - and yes, atazanavir looks very good with regard to the lipid issues.
Should i start HAART
- Itchy Red Spots After Drinking After Someone Sign Of HIV AIDS
- Sore Throat After Oral Sex With No Protection Does It Mean I Have HIV
- I Have A Discharge Does That Mean I Have A Std
- Symptoms Of Vaginal Bleeding Headache Low Back Pain Cramping
- Deep Kissing And Sucking Neck Hiv Risk
- Hand Job With Suspected Vaginal Fluids
This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.
Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.